| __timestamp | Amphastar Pharmaceuticals, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 52602000 |
| Thursday, January 1, 2015 | 77347000 | 105812000 |
| Friday, January 1, 2016 | 104189000 | 113485000 |
| Sunday, January 1, 2017 | 90795000 | 285461000 |
| Monday, January 1, 2018 | 106985000 | 141726000 |
| Tuesday, January 1, 2019 | 131923000 | 150446000 |
| Wednesday, January 1, 2020 | 143340000 | 224227000 |
| Friday, January 1, 2021 | 199739000 | 361897000 |
| Saturday, January 1, 2022 | 248860000 | 520812000 |
| Sunday, January 1, 2023 | 351121000 | 636892000 |
Unleashing insights
In the competitive landscape of biotechnology and pharmaceuticals, understanding financial performance is crucial. Over the past decade, Halozyme Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc. have shown remarkable growth in gross profit. From 2014 to 2023, Halozyme's gross profit surged by over 1,100%, reaching approximately $637 million in 2023. Amphastar, while trailing, demonstrated a robust increase of nearly 585%, culminating in a gross profit of around $351 million in the same year.
This trend highlights Halozyme's aggressive growth strategy, outpacing Amphastar by a significant margin. The data underscores the dynamic nature of the industry, where strategic investments and innovations can lead to substantial financial gains. As these companies continue to evolve, stakeholders and investors should keep a keen eye on their financial trajectories, which reflect broader industry trends and potential future opportunities.
Gross Profit Comparison: Merck & Co., Inc. and Amphastar Pharmaceuticals, Inc. Trends
Amgen Inc. vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing GSK plc and Amphastar Pharmaceuticals, Inc.
Biogen Inc. vs Halozyme Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc. Trends
BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Walgreens Boots Alliance, Inc. and Halozyme Therapeutics, Inc. Trends
Halozyme Therapeutics, Inc. and MorphoSys AG: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Bausch Health Companies Inc.
Gross Profit Comparison: Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc. Trends